The Dimerix Limited Clinical Trials – ACTION for Diabetic Kidney Disease and ACTION for Focal Segmental Glomerulosclerosis – Are Now Open!
Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)
Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs
Recent news and media
More information available here